Life Sciences Tools and Services
Company Overview of ForteBio, Inc.
ForteBio, Inc. develops, produces, and supplies analytical systems for protein quantification or characterization of protein-protein interaction. It offers Octet family of instruments, biosensors, reagents, and assay kits for analyzing biomolecular interactions in micrplate format for proteins, peptides, DNA, RNA, and small molecules, as well as to provide information on affinity, kinetics, and concentration. The company also provides biosensors and assays, including immunogenicity assay kits, residual protein A detection assay kits, custom host cell protein kits, amine reactive second-generation reagent kits to analyze specific biomolecular interactions; 384-well tilted bottom plates for th...
1360 Willow Road
Menlo Science & Technology Park
Menlo Park, CA 94025
Founded in 2001
Key Executives for ForteBio, Inc.
Vice President of Product Development and Operations
Vice President of China Operations
Compensation as of Fiscal Year 2013.
ForteBio, Inc. Key Developments
ForteBio, Inc. Launches New Interaction Analysis System
Sep 20 13
ForteBio, Inc. has launched the Octet HTX system, the new member of the Octet line of label-free interaction analysis systems. The Octet HTX system addresses the acute industry need for increased analysis speed and sample throughput when characterizing large numbers of therapeutic candidates, the company said. Octet systems provide unique insights into drug-target binding interactions, insights that are used to fine-tune the affinity and specificity of drug molecules. The Octet HTX instrument performs kinetic analysis of up to 96 binding interactions simultaneously, a capability offered by no other stand-alone label-free platform. In addition, the Octet HTX performs full 96-well plate determinations of protein concentrations in as little as 2 minutes.
Avacta Group plc Announces Expansion of Collaboration with Fortebio
Jul 25 13
Avacta Group plc announced that it has extended its commercial collaboration with ForteBio. Avacta has entered into a distribution agreement with ForteBio for the sale of Optim, the group's protein analysis product, in China, Hong Kong and Taiwan. Optim has been developed to accelerate and reduce the cost of drug development by providing early analysis of compounds to identify the best candidates and to define the optimal processing conditions. In the critical stages of pre-formulation, stability testing and formulation of biopharmaceutical drugs, Optim delivers vital information tens of times faster than other approaches, using sample sizes less than a hundredth the size of those needed by existing techniques. Optim comprises a benchtop instrument, analysis software and a single-use sample holder that leads to recurring consumables revenues.
ForteBio Launches New Dip and Read Anti-FLAG Biosensor to Facilitate Protein Research and Drug Development
Feb 12 13
ForteBio announced the launch of its new Dip and Read(TM) Anti-FLAG Biosensor for use on the company's Octet(R) and BLItz(TM) instrumentation systems. The new biosensor enables researchers to quickly and easily detect FLAG-tagged recombinant proteins for their quantitation and kinetic characterization, which are key steps in drug development. The Dip and Read(TM) Anti-FLAG Biosensor for use on ForteBio's Octet(R) and BLItz(TM) instrumentation systems enables researchers to quickly and easily detect FLAG-tagged recombinant proteins for their quantitation and kinetic characterization. The biosensor is pre-immobilized with Sigma-Aldrich's well-established, high-affinity ANTI-FLAG(R) M2 antibody, which has been cited in more than 30,000 journal articles over the last two decades. The high specificity of the antibody-based biosensor enables the direct quantitation of FLAG-tagged analytes in crude lysates, column eluents, cell lysates and cell culture supernatants.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|